PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.38 +0.31 (+1.54%)
As of: Sep 11, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Cash & Equivalents Growth (3y) (2023 - 2026)

Analysis

PROCEPT BioRobotics (PRCT) Cash & Equivalents Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn -13.31%
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn -7.03%
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 8.09%
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 34.27%
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 8.16%
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn 40.74%
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn 27.03%
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn -2.57%
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 32.23%
10 PROCEPT BioRobotics 1.17 Bn 895.36 Mn 62.38 Mn 22.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.49%
Mar 31, 2026 10.72%
Dec 31, 2025 8.90%
Sep 30, 2025 5.70%
Jun 30, 2025 3.91%
Mar 31, 2025 3.61%
Dec 31, 2024 3.12%
Sep 30, 2024 -15.01%
Jun 30, 2024 10.37%
Mar 31, 2024 37.85%
Dec 31, 2023 36.96%
Sep 30, 2023 36.31%